/PRNewswire/ DelveInsight s Anti-Radiation Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-radiation.
The rise in demand for anti-radiation drugs is mainly driven by several factors. These include the growing occurrence of side effects linked to cancer screening methods, heightened risks of
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) Director Daniel K. Spiegelman sold 3,788 shares of Myriad Genetics stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $22.04, for a total transaction of $83,487.52. Following the sale, the director now directly owns 36,705 shares in the company, […]
SALT LAKE CITY, June 03, 2024 Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College.